BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lipitor
,
rs2230926
,
SIRT1
,
calcium channel activity
,
Inflammatory disorder
,
Alcohol
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
1 4- naphthoquinone
Summary
General Info
Curated Studies
Most Correlated Studies
Lung airway epithelial cell lines CTFR mutant or wildtype under oxidative stress
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Broad Connectivity Map (CMAP 2.0) compound database
Explore Curated Studies Results
Literature
Most Relevant Literature
Synthesis and biological activity against Trypanosoma cruzi of substituted 1,4-naphthoquinones.
SERS investigations of 2,3-dibromo-1,4-naphthoquinone on silver nanoparticles.
Antitrypanosomal activities and cytotoxicity of some novel imido-substituted 1,4-naphthoquinone deri…
Reviews on 1,4-naphthoquinones from Diospyros L.
Singlet oxygen production by pyrano and furano 1,4-naphthoquinones in non-aqueous medium.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
MaxSimil and Vitamin K2: Determining Their Bioavailability
A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Tre…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ